Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease. - Wikidata - wikimedia - TriplyDB

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

http://www.wikidata.org/entity/Q36157810

about

Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease p62 improves AD-like pathology by increasing autophagy Palmitic Acid-BSA enhances Amyloid-β production through GPR40-mediated dual pathways in neuronal cells: Involvement of the Akt/mTOR/HIF-1α and Akt/NF-κB pathways Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease.Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease.Transcriptomic alterations in the brain of painted turtles (Chrysemys picta) developmentally exposed to bisphenol A or ethinyl estradiol.Forebrain depletion of Rheb GTPase elicits spatial memory deficits in mice.Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies.Practical considerations for choosing a mouse model of Alzheimer's disease.miR-181a Participates in Contextual Fear Memory Formation Via Activating mTOR Signaling Pathway.Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease.Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.

P2860

Q26770762-69CB9920-7A06-4C08-AA47-8D905C2FDD4F Q27303472-05A3B48F-7F52-411B-8ECA-40DEA684B54B Q28277112-C24CA6DF-2707-4E41-86F1-877EA6FE0224 Q33821175-81D10AED-DF53-47EF-A79E-86854E4CE875 Q33849216-B56034AC-1A8B-40D4-BB87-4404B0E2BA00 Q37144985-28E2F0D7-8457-4A4E-BF58-2E8048B78AE1 Q37565965-B3A811D2-47C8-4891-9ADB-7B2A054EC2B7 Q37662094-27794028-5F75-4CF2-AC49-AC1F97032621 Q38402904-23C3032D-4845-4D98-9F8F-88B6B4CC2E2C Q38434419-269FFAC0-E80E-4329-A65E-57E96E2C7A15 Q38688226-31A404C5-6007-4551-9A06-EA666A9F835C Q38712234-19DC513B-4B50-4FF0-A48C-F622A7881585 Q38815881-356A7584-0291-49CF-AF1C-921466907B7B Q47135235-A55ED10F-B286-4049-A981-137FC1816381 Q47608479-4F964C4F-C3EE-4158-994B-647A521D9CD5 Q47784892-91ECAE0E-C912-4A5E-B98B-04EBCA6D1703 Q47867970-88021CF0-D85F-42BF-B30B-473F93B67FFF Q48060988-95A78F6A-47A4-4617-A8A0-451C5EB7565A Q49256155-26096739-25BA-4810-A18A-61380EE89CC7 Q50546416-57388414-B8E3-44F8-BABD-6717CE788512

P2860

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

http://www.wikidata.org/entity/Q36157810

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@ast

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@en

type

label

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@ast

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@en

prefLabel

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@ast

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@en

P1433

Q36157810-0EAB9930-C670-4DE8-83A1-F66408FF4A0E

P1476

Q36157810-C3F0E2EB-94C6-413B-A877-10CF9A1A043D

P2093

Q36157810-09578182-D9D0-4FC4-8B9E-5AB350CEE555

Q36157810-231674A0-DB8E-442C-A3A7-346D373CA9C2

Q36157810-4CA92720-5CB8-4468-A3C5-30D29D176850

Q36157810-60B5FED4-6874-4432-9306-90F508E52F1B

Q36157810-6AD31EDB-C72F-4B97-91D4-FCF0D7DD4A87

Q36157810-74756EC6-95B2-4CC8-8AF5-D1FA63793BCB

Q36157810-A790BBE3-CACE-4F50-BDED-148D6BA9D551

Q36157810-D7995D75-705C-4A43-BDE3-21441322C2E0

Q36157810-DE69F856-E3A8-40E4-B258-58C51D501EE0

Q36157810-ED1FC6E9-8B2F-4B30-BE4D-D2910EB81AEC

P2860

Q36157810-117BF2E6-87E6-4732-AB59-35E8559D32BB

Q36157810-2364BCC4-025B-4BFA-BF12-4EC5387AAE48

Q36157810-25C57906-88F1-47FD-8DE7-1DC51E0802CD

Q36157810-2F669C31-4F02-4257-9AF8-5A875541AE7D

Q36157810-2FA339D1-AF97-4904-A0C6-9F1B58E78843

Q36157810-34251450-9C96-45E2-90E5-0083E658D45A

Q36157810-35C179B6-CC74-4D51-ADDB-8A453A17411E

Q36157810-377555D0-2642-4048-A3C4-55FF1DB03B55

Q36157810-37B83358-81F0-4D72-A25C-E023A219C9D3

Q36157810-3BF33300-5D80-461B-BA90-9ACE3312DA14

P304

Q36157810-F8A6BD6E-0D3D-438E-BC12-166CE34A521A

P31

Q36157810-5E6B8E2D-3A3B-430A-83E5-8A9511C9130E

P356

Q36157810-93E0203C-871C-45E3-AFDF-FA5E62FB9E5F

P407

Q36157810-14BF3F02-5D41-4F69-AE34-76B3DEB4D89A

P433

Q36157810-C4B89B3F-4346-423B-A17B-4000B3D605DC

P478

Q36157810-20DFE59D-840B-4118-A575-1B5D45B210F1

P577

Q36157810-B83AA7C6-BE83-4307-AF78-2013ECF23A46

P698

Q36157810-5DA76C75-3FB9-4EF8-B7CD-6A25377849C3

P921

Q36157810-3D179ED2-C3E0-4D21-B2C3-717443E3265F

P932

Q36157810-B5FA7673-4B43-4CAE-B699-F7B4102E5074

P356

JNEUROSCI.2781-15.2015

P1433

Journal of Neuroscience

P1476

Reducing Ribosomal Protein S6 ...... Model of Alzheimer's Disease.

@en

P2093

Angela Messina

http://www.w3.org/2001/XMLSchema#string

Antonella Caccamo

http://www.w3.org/2001/XMLSchema#string

Caterina Branca

http://www.w3.org/2001/XMLSchema#string

Darren M Shaw

http://www.w3.org/2001/XMLSchema#string

Dharshaun Turner

http://www.w3.org/2001/XMLSchema#string

Jie Wu

http://www.w3.org/2001/XMLSchema#string

Joshua S Talboom

http://www.w3.org/2001/XMLSchema#string

Luyao Ma

http://www.w3.org/2001/XMLSchema#string

Salvatore Oddo

http://www.w3.org/2001/XMLSchema#string

Zebing Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism

Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis

Synapses and Alzheimer's disease

Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers

Connecting the dots between tau dysfunction and neurodegeneration

An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

P304

14042-14056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.2781-15.2015

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26468204

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4604237

http://www.w3.org/2001/XMLSchema#string